Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of hematologic malignancies with an anti-CXCR4 antibody

Treatment of hematologic malignancies with an anti-CXCR4 antibody

US Patent 10428151 · Granted Oct 1, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies against TIM3 and uses thereof2025
Antibodies against TIM3 and uses thereof2024
Antibodies against TIM3 and uses thereof2023
Human monoclonal antibodies that bind CXCR4 and uses thereof2022
Human monoclonal antibodies that bind CXCR4 and uses thereof2022
Treatment of C1013G/CXCR4-associated Waldenstrom's macroglobulinemia with an ant2022
FLT3L-FC fusion proteins2021
Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibod2021
Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibod2021
Interferon receptor 1 antibodies and their uses2021
Antibodies against TIM3 and uses thereof2020
Monoclonal antibodies to programmed death 1 (PD-1)2019